A number of late-phase clinical trials in prostate cancer have opened in recent months. Maybe one of your patients could
Continue reading »
mypharmacynews.com
Home »
A number of late-phase clinical trials in prostate cancer have opened in recent months. Maybe one of your patients could
Continue reading »Nearly 80% of men with metastatic prostate cancer died from their malignancy, according to a retrospective cohort study involving 26,000-plus
Continue reading »In a randomized trial of prostate cancer screening methods, a blood-based diagnostic test and MRI with subsequent targeted plus systematic
Continue reading »NEW YORK (Reuters Health) – Biomarkers can be used to identify patients with prostate cancer refractory to first-line androgen deprivation
Continue reading »NEW YORK (Reuters Health) – Loss of MAP3K7 protein expression, seen in approximately 40% of prostate cancer patients, is a
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. COMTAN® entacapone Consumer Medicine Information What is
Continue reading »NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MARVELON® 28 (mar-ve-lon) Ethinylestradiol and Desogestrel Consumer
Continue reading »An artificial nose developed at Tampere University, Finland, helps neurosurgeons to identify cancerous tissue during surgery and enables more precise
Continue reading »Now there is additional evidence of the connection between the intake of antioxidant supplements and increased tumor growth. Experiments on
Continue reading »